Related Experiment Video
Updated: Jun 29, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Antineoplastic properties of bacteriocins: revisiting potential active agents
Gilbert Cornut1, Claude Fortin, Denis Soulières
1Department of Microbiology, Service of Hematology and Medical Oncology, Centre Hospitalier de l'Université de Montréal and Centre de Recherche du CHUM, Montreal, Québec, Canada.
Abstract:
Bacteriocins are antimicrobial peptides produced by a wide range of bacteria. Their antineoplastic properties have been inadequately revealed in the late 70s by using crude bacteriocin preparation toxic to mammalian cells. Nowadays, purified bacteriocins are available and have shown inhibitory properties toward diverse neoplastic line cells. Pyocin, colicin, pediocin, and microcin are among bacteriocins reported to present such activity. Moreover, modified bacteriocins proved to be effective in a glioblastoma xenograft mouse model. Screening for the presence of bacteriocin in colon cancer subjects has been studied with mixed results. Bacteriocin use as a therapeutic agent or in a prevention setting is discussed specifically evaluating bacteriocins biochemical properties and recent advances in peptide therapeutics.
More Related Videos
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Biological Methods for Microbial Control
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Bacterial Toxins

